In Silico Analysis of Conformational Changes Induced by Normal and Mutation of Macrophage Infectivity Potentiator Catalytic Residues and its Interactions with Rapamycin
暂无分享,去创建一个
[1] J. Natarajan,et al. Combination of site directed mutagenesis and secondary structure analysis predicts the amino acids essential for stability of M. leprae MurE , 2014, Interdisciplinary Sciences: Computational Life Sciences.
[2] I. Adzhubei,et al. Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2 , 2013, Current protocols in human genetics.
[3] Chris Morley,et al. Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.
[4] U. Holzgrabe,et al. Pipecolic acid derivatives as small-molecule inhibitors of the Legionella MIP protein. , 2011, Journal of medicinal chemistry.
[5] R. Vijayan,et al. In silico Modeling of 1A-Adrenoceptor: Interaction of its Normal and Mutated Active Sites with Noradrenaline as well as its Agonist and Antagonist , 2007 .
[6] M. Schroeder,et al. LIGSITEcsc: predicting ligand binding sites using the Connolly surface and degree of conservation , 2006, BMC Structural Biology.
[7] Arlo Z. Randall,et al. Prediction of protein stability changes for single‐site mutations using support vector machines , 2005, Proteins.
[8] Piero Fariselli,et al. I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure , 2005, Nucleic Acids Res..
[9] H. Ke,et al. Structures of calcineurin and its complexes with immunophilins-immunosuppressants. , 2003, Biochemical and biophysical research communications.
[10] Jie Liang,et al. CASTp: Computed Atlas of Surface Topography of proteins , 2003, Nucleic Acids Res..
[11] J. Heitman. Faculty Opinions recommendation of Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes. , 2002 .
[12] A. Sali,et al. Comparative protein structure modeling of genes and genomes. , 2000, Annual review of biophysics and biomolecular structure.
[13] G. Koehl,et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor , 2002, Nature Medicine.
[14] J. Hacker,et al. Crystal structure of Mip, a prolylisomerase from Legionella pneumophila , 2001, Nature Structural Biology.
[15] P Willett,et al. Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.
[16] J. Hacker,et al. Influence of site specifically altered Mip proteins on intracellular survival of Legionella pneumophila in eukaryotic cells , 1995, Infection and immunity.
[17] D. Kamp,et al. Infectivity of Legionella pneumophila mip mutant for alveolar epithelial cells , 1995, Current Microbiology.
[18] J. Hacker,et al. Studies on the uptake and intracellular replication of Legionella pneumophila in protozoa and in macrophage-like cells , 1994 .
[19] J. Hacker,et al. Characterization of Mip proteins of Legionella pneumophila. , 1994, FEMS microbiology letters.
[20] J. Hacker,et al. Mip protein of Legionella pneumophila exhibits peptidyl‐prolyl‐cis/trans isomerase (PPIase) activity , 1992, Molecular microbiology.
[21] W. Winn,et al. Legionnaires disease: historical perspective , 1988, Clinical Microbiology Reviews.
[22] Rowbotham Tj,et al. Current views on the relationships between amoebae, legionellae and man. , 1986 .
[23] T. Rowbotham,et al. Preliminary report on the pathogenicity of Legionella pneumophila for freshwater and soil amoebae. , 1980, Journal of clinical pathology.
[24] W. Dowdle,et al. Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. , 1977, The New England journal of medicine.
[25] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[26] M. Suthanthiran,et al. Which way for drug-mediated immunosuppression? , 1994, Current opinion in immunology.
[27] T. Rowbotham. Current views on the relationships between amoebae, legionellae and man. , 1986, Israel journal of medical sciences.